Skip to content

Multicenter study on the safety and effectiveness of clinical application of tunnel PICC guided by EDUG

Multicenter study on the safety and effectiveness of clinical application of tunnel PICC guided by EDUG

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063542
Enrollment
Unknown
Registered
2022-09-10
Start date
2022-12-26
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Interventions

Experiment group:Tunnel PICC
Control group :General PICC

Sponsors

The Second Affiliated Hospital of Lanzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 120 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged >= 18 years; 2. Patients with PICC catheterization for the first time according to medical advice; 3. Patients who voluntarily participate in the clinical study and can cooperate with clinical follow-up.

Exclusion criteria

Exclusion criteria: 1. Patients with local deformity or scar formation; 2. Patients with infection or damage at the puncture site; 3. Patients with venous sclerosis and cord-like changes; 4. Patients with tumor-compressing blood vessels; 5. Patients with confirmed or suspected catheter-related infection, bacteremia, and sepsis; 6. Patients whose body shape is not suitable for PICC implantation; 7. Patients with confirmed or suspected allergy to silicone material; 8. Patients with a history of radiotherapy at the pre-intubation site; 9. Patients with a history of venous thrombosis, trauma, or vascular surgery; 10. Patients with superior vena cava syndrome; 11. Patients with poor medical behavior; 12. Patients with severe peripheral vascular edema; 13. Patients with serious cardiovascular diseases such as atrial fibrillation, cor pulmonale, and severe conduction block before catheterization; 14. Patients with a high flow of infusion fluid, require hemodialysis, pacemaker installation, crutches, or A-V ostomy.

Design outcomes

Primary

MeasureTime frame
Catheter-related infections rate (Catheter puncture site infections and CRBSI);Catheter detachment rate;Active exudate at the puncture site after 48 hours;Catheter-related thrombosis;

Secondary

MeasureTime frame
Patient bleeding during the operation proces;Unplanned extubation rate;Operation time;pain;Comfort;

Countries

China

Contacts

Public ContactDou Xinman

The Second Affiliated Hospital of Lanzhou University

dxm1812@163.com+86 931 894 2249

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026